EUVIMEDEUVIMED entdecken
Vergleichsstudie

Safety and Efficacy of Bivalirudin as a Heparin Alternative in Patients Undergoing Carotid Artery Stenting

Thomas A Kania, Sahaj Shah, Tian Guo, Alexandra L Maningat, Anthony J Lewis, Evan J Ryer, James Elmore, Gregory G Salzler

Annals of Vascular Surgery · 2026

DOI: 10.1016/j.avsg.2025.05.034 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Annals of Vascular Surgery, 2026. Verfasst von Thomas A Kania und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Vascular and Endovascular Surgery, Geisinger Medical Center, Danville, PA. Hauptthemen laut MEDLINE: Hirudins, Peptide Fragments, Heparin, Stents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Transfemoral carotid artery stenting (TFCAS) and transcarotid artery revascularization (TCAR) are commonly used to treat carotid stenosis. However, the need for heparin alternatives during these procedures and their impact on outcomes remain unclear. This study evaluates the safety and efficacy of bivalirudin, the most commonly used heparin alternative, compared to heparin. METHODS: The Vascular Quality Initiative registry was queried for carotid artery stenting procedures performed from 2010 to 2022. Propensity-matched analyses compared outcomes between patients receiving intraprocedural heparin and those receiving bivalirudin. Primary outcomes were postoperative neurological events, including stroke or transient ischemic attack, and bleeding. Secondary outcomes included 30-day rates of reintervention and myocardial infarction, and mortality at 30 days and 1 year. RESULTS: Among 80,172 carotid artery stenting procedures, 2,789 (3.47%) were performed with bivalirudin. In the heparin group, 24,797 (34.1%) underwent TFCAS with distal embolic protection, while 47,961 (65.9%) underwent TCAR with flow reversal. In the bivalirudin group, 2,494 (91.2%) underwent TFCAS, and 240 (8.8%) underwent TCAR. Propensity matching created 2 cohorts of 957 patients each. There were no significant differences in neurological events (odds ratio, [OR]: 1.44, 95% confidence interval [CI]: 0.72-2.86; P = 0.30), bleeding (OR: 1.0, 95% CI: 0.53-1.90; P = 1.00), 30-day mortality (OR: 2.05, 95% CI: 0.62-6.85; P = 0.24), or 1-year mortality (OR: 1.37, 95% CI: 0.84-2.24; P = 0.21). CONCLUSION: Bivalirudin is a safe and effective alternative to heparin for patients with contraindications to heparin undergoing carotid artery stenting. These findings suggest no significant differences in outcomes, supporting bivalirudin as a viable anticoagulation option.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HirudinsPeptide FragmentsHeparinStentsCarotid StenosisAntithrombinsEndovascular ProceduresAnticoagulantsHumansMaleFemaleAgedRecombinant ProteinsTreatment OutcomeRegistriesRisk FactorsTime FactorsAged, 80 and overMiddle AgedRetrospective StudiesRisk AssessmentHemorrhageStroke

Substanzen

bivalirudinHirudinsRecombinant ProteinsPeptide FragmentsHeparinAntithrombinsAnticoagulants

Autor:innen und Institutionen

  • Department of Vascular and Endovascular Surgery, Geisinger Medical Center, Danville, PA.
  • Geisinger Commonwealth SOM, Scranton, PA.
  • Department of Biostatistics, Geisinger Medical Center, Danville, PA.
  • Department of Vascular and Endovascular Surgery, Geisinger Medical Center, Danville, PA. Electronic address: gsalzler@geisinger.edu.

Zitieren

APA

Kania, T. A., Shah, S., Guo, T., Maningat, A. L., Lewis, A. J., Ryer, E. J., Elmore, J., & Salzler, G. G. (2026). Safety and Efficacy of Bivalirudin as a Heparin Alternative in Patients Undergoing Carotid Artery Stenting. Annals of Vascular Surgery. https://doi.org/10.1016/j.avsg.2025.05.034

Vancouver

Kania TA, Shah S, Guo T, Maningat AL, Lewis AJ, Ryer EJ, et al. Safety and Efficacy of Bivalirudin as a Heparin Alternative in Patients Undergoing Carotid Artery Stenting. Annals of Vascular Surgery. 2026. doi:10.1016/j.avsg.2025.05.034

BibTeX
@article{Kania2026,
  author = {Kania, Thomas A and Shah, Sahaj and Guo, Tian and Maningat, Alexandra L and Lewis, Anthony J and Ryer, Evan J and Elmore, James and Salzler, Gregory G},
  title = {Safety and Efficacy of Bivalirudin as a Heparin Alternative in Patients Undergoing Carotid Artery Stenting},
  journal = {Annals of Vascular Surgery},
  year = {2026},
  doi = {10.1016/j.avsg.2025.05.034}
}
Kostenlos starten →